Juan Hu

Dr. Juan Hu

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
ZZZhifeng Zhong
Zhifeng Zhong
JHJing Han
Jing Han
JZJizhou Zhang
Jizhou Zhang
QXQing Xiao
Qing Xiao
JHJuan Hu
Juan Hu
LCLidian Chen
Lidian Chen
The primary objective of this review article was to summarize comprehensive information related to the neuropharmacological activity, mechanisms of action, toxicity, and safety of salidroside in medicine. A number of studies have revealed that salidroside exhibits neuroprotective activities, including anti-Alzheimer’s disease, anti-Parkinson’s disease, anti-Huntington’s disease, anti-stroke, anti-depressive effects, and anti-traumatic brain injury; it is also useful for improving cognitive function, treating addiction, and preventing epilepsy. The mechanisms underlying the potential protective effects of salidroside involvement are the regulation of oxidative stress response, inflammation, apoptosis, hypothalamus-pituitary-adrenal axis, neurotransmission, neural regeneration, and the cholinergic system. Being free of side effects makes salidroside potentially attractive as a candidate drug for the treatment of neurological disorders. It is evident from the available published literature that salidroside has potential use as a beneficial therapeutic medicine with high efficacy and low toxicity to the central nervous system. However, the definite target protein molecules remain unclear, and clinical trials regarding this are currently insufficient; thus, guidance for further research on the molecular mechanisms and clinical applications of salidroside is urgent.

16 October 2013 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
JHJuan Hu
Juan Hu
WPWensheng Pang
Wensheng Pang
JCJinlong Chen
Jinlong Chen
SBShaowei Bai
Shaowei Bai
ZZZhenzhu Zheng
Zhenzhu Zheng
XWXiaohua Wu
Xiaohua Wu
The aims of this study were to evaluate the antidiabetic activity and to detect molecular size of Pseudostellaria heterophylla polysaccharide (PHP). Pseudostellaria heterophylla is a medicine extensively used in traditional Chinese medicine formulas to treat diabetes and its complications.

19 April 2011 in Molecules
Verified
Journal Article
Open access
PDF file
WPWensheng Pang
Wensheng Pang
SLSiding Lin
Siding Lin
QDQiwen Dai
Qiwen Dai
HZHongcheng Zhang
Hongcheng Zhang
JHJuan Hu
Juan Hu
Pseudostellaria heterophylla (Miq.) Pax is one of the most widespread herbal and healthcare products in China. Extensive clinical use has shown that it has functions which “strengthens qi and generates saliva, moistens the lung and relieves cough”. The ethyl acetate fraction extracted from the roots of the plant Pseudostellaria heterophylla exhibited a dose-dependent antitussive effect between 100 to 500 mg/kg. At a dose of 400 mg/kg, the ethyl acetate fraction treatment markedly prolonged the cough latent period and reduced the number of coughs in a guinea pig model induced by citric acid. Fall lung airway resistance, rise in dynamic lung compliance, decreased serum levels of IL-8, GM-CSF, TNF-α, and ET-1 in rat model of stable phase chronic obstructive pulmonary disease induced by cigarette smoke exposure were also observed. These results suggest that ethyl acetate fraction has antitussive activity related to its improvement in lung function via attenuation of airway inflammation by adjustment of multi-cytokine levels.

13 December 2019 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
ZZZhi-Feng Zhong
Zhi-Feng Zhong
JHJing Han
Jing Han
JZJi-Zhou Zhang
Ji-Zhou Zhang
QXQing Xiao
Qing Xiao
JCJing-Yan Chen
Jing-Yan Chen
LCLidian Chen
Lidian Chen
Salidroside, a phenylpropanoid glycoside, is the main bioactive component of Rhodiola rosea L. Salidroside has prominent anti-stroke effects in cerebral ischemia/reperfusion models. However, the underlying mechanisms of its actions are poorly understood. This study examined the anti-stroke effects of salidroside in middle cerebral artery occlusion (MCAO)-induced rat model of stroke and its potential mechanisms involving the dopaminergic system. Salidroside administration increased the levels of dopamine (DA), homovanillic acid (HVA), and 3,4-dihydroxyphenylacetic acid (DOPAC) in the ipsilateral striatum after induction of transient ischemia, which were assessed using microdialysis with high-performance liquid chromatography coupled with electrochemical detection (HPLC-ECD). Furthermore, treatment with salidroside ameliorated neurobehavioral impairment, assessed with the modified neurological severity scores (mNSS), the balance beam test, and the foot fault test. Moreover, enzyme-linked immunosorbent assay (ELISA) suggested that MCAO-induced reduction in monoamine oxidase (MAO) was inhibited by salidroside. Immunohistochemical and immunofluorescence analyses revealed high level of tyrosine hydroxylase (TH) in the ipsilateral striatal caudate putamen (CPu) after cerebral ischemia/reperfusion, which could be further elevated by salidroside. In addition, salidroside could reverse the decreased immunoreactivity of TH in the substantia nigra pars compacta (SNpc). These results suggest that the anti-stroke effects of salidroside in MCAO-induced cerebral ischemia/reperfusion may involve the modulation of monoamine metabolism in the striatum and SNpc, which may be related to the function of the dopaminergic system in the rat brain.

1 January 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
JCJinlong Chen
Jinlong Chen
WPWensheng Pang
Wensheng Pang
YKYongjun Kan
Yongjun Kan
LZLi Zhao
Li Zhao
ZHZhaodong He
Zhaodong He
JHJuan Hu
Juan Hu

1 January 2015 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
JHJuan Hu
Juan Hu
JHJing Han
Jing Han
QXQing Xiao
Qing Xiao
YLYan-Hua Lin
Yan-Hua Lin
ZZZhen-Zhu Zheng
Zhen-Zhu Zheng
LCLi-Dian Chen
Li-Dian Chen
Salidroside, the main active ingredient extracted from Rhodiola crenulata, has been shown to be neuroprotective in ischemic cerebral injury, but the underlying mechanism for this neuroprotection is poorly understood. In the current study, the neuroprotective effect of salidroside on cerebral ischemia-induced oxidative stress and the role of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway was investigated in a rat model of middle cerebral artery occlusion. Salidroside (30 mg/kg) reduced infarct size, improved neurological function and histological changes, increased activity of superoxide dismutase and glutathione-S-transferase, and reduced malon-dialdehyde levels after cerebral ischemia and reperfusion. Furthermore, salidroside apparently increased Nrf2 and heme oxygenase-1 expression. These results suggest that salidroside exerts its neuroprotective effect against cerebral ischemia through anti-oxidant mechanisms and that activation of the Nrf2 pathway is involved. The Nrf2/antioxidant response element pathway may become a new therapeutic target for the treatment of ischemic stroke.